The effect of extracorporeal shock wave therapy on the treatment of moderate to severe knee osteoarthritis and cartilage lesion

This 2019 clinical trial compared extracorporeal shock wave therapy (ESWT) to NSAID therapy in 186 patients with moderate to severe knee osteoarthritis (KOA). The ESWT group (n=82) received 0.25 mJ/mm² at 2.0 bar, 8 Hz, twice weekly for 4 weeks. The NSAID group (n=104) received standard oral anti-inflammatory treatment. Pain